EDWARD EVARD: Open Payments
NPI 1396344693 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,303 in 164 payments from 17 companies in 2025. Trend: 2023 $1,667 · 2024 $1,786 · 2025 $3,303
Food & beverage: $3,303
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $544 |
| Janssen Pharmaceuticals, Inc | 11 | $540 |
| E.R. Squibb & Sons, L.L.C. | 19 | $426 |
| Neurocrine BioSciences, Inc. | 16 | $267 |
| Vanda Pharmaceuticals Inc. | 9 | $229 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $225 |
| Axsome Therapeutics, Inc. | 13 | $183 |
| Alkermes, Inc. | 8 | $174 |
| Supernus Pharmaceuticals, Inc. | 12 | $156 |
| Otsuka America Pharmaceutical, Inc. | 5 | $127 |
Products named: VRAYLAR, COBENFY, SPRAVATO, INGREZZA, FANAPT, CAPLYTA, ARISTADA, Qelbree.
Industry payments across VA — which companies pay providers there.
